After Piper Jaffray and Citigroup gave Intuitive Surgical (NASDAQ: ISRG) a Buy rating last month, the company received another Buy, this time from Merrill Lynch. Analyst Bob Hopkins reiterated a Buy rating on Intuitive Surgical today and set a price target of $600. The company’s shares opened today at $501.
Hopkins has an average return of 20.9% when recommending Intuitive Surgical.
According to TipRanks.com, Hopkins is ranked #733 out of 5135 analysts.
Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $603.13, a 20.4% upside from current levels. In a report issued on January 2, Citigroup also maintained a Buy rating on the stock with a $560 price target.
.
See today’s analyst top recommended stocks >>
Intuitive Surgical’s market cap is currently $55.16B and has a P/E ratio of 72.20. The company has a Price to Book ratio of 8.78.
Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
